These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 2456631

  • 1. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 2. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
    Frederick DL, Ali SF, Slikker W, Gillam MP, Allen RR, Paule MG.
    Neurotoxicol Teratol; 1995 May 29; 17(5):531-43. PubMed ID: 8551999
    [Abstract] [Full Text] [Related]

  • 8. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
    Gough B, Imam SZ, Blough B, Slikker W, Ali SF.
    Ann N Y Acad Sci; 2002 Jun 19; 965():410-20. PubMed ID: 12105116
    [Abstract] [Full Text] [Related]

  • 10. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb 19; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 11. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May 19; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
    Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA.
    J Pharmacol Exp Ther; 1993 Mar 19; 264(3):1484-91. PubMed ID: 7680719
    [Abstract] [Full Text] [Related]

  • 13. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.
    Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW.
    JAMA; 1988 Jul 01; 260(1):51-5. PubMed ID: 2454332
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.
    Gough B, Ali SF, Slikker W, Holson RR.
    Pharmacol Biochem Behav; 1991 Jul 01; 39(3):619-23. PubMed ID: 1723797
    [Abstract] [Full Text] [Related]

  • 15. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI, Green AR.
    Br J Pharmacol; 1994 Jan 01; 111(1):131-6. PubMed ID: 7516800
    [Abstract] [Full Text] [Related]

  • 16. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA, Martello AL, Katz JL, Martello MB.
    J Pharmacol Exp Ther; 1992 May 01; 261(2):616-22. PubMed ID: 1374470
    [Abstract] [Full Text] [Related]

  • 17. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates.
    Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW.
    Brain Res; 1988 Dec 06; 474(2):359-63. PubMed ID: 2463059
    [Abstract] [Full Text] [Related]

  • 18. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 06; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 19. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.
    Logan BJ, Laverty R, Sanderson WD, Yee YB.
    Eur J Pharmacol; 1988 Aug 02; 152(3):227-34. PubMed ID: 2906000
    [Abstract] [Full Text] [Related]

  • 20. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS.
    J Pharmacol Exp Ther; 1987 Apr 02; 241(1):338-45. PubMed ID: 2883295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.